Published in Annu Rev Cell Biol on January 01, 1987
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J (1991) 6.00
Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol (1991) 4.46
Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J (1991) 3.98
Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol (1989) 3.15
Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci U S A (1993) 2.95
Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci U S A (1993) 2.74
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol (1999) 2.40
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci U S A (1993) 2.35
Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J Virol (1994) 1.64
Replication of bovine papillomavirus type 1 DNA initiates within an E2-responsive enhancer element. J Virol (1990) 1.64
Viral and nonviral delivery systems for gene delivery. Adv Biomed Res (2012) 1.42
Cellular factors required for papillomavirus DNA replication. J Virol (1995) 1.33
Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A. J Virol (1995) 1.33
Evidence that replication initiates at only some of the potential origins in each oligomeric form of bovine papillomavirus type 1 DNA. Mol Cell Biol (1990) 1.28
Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines. J Virol (1992) 1.14
Bovine papillomavirus E1 protein can, by itself, efficiently drive multiple rounds of DNA synthesis in vitro. J Virol (1995) 1.14
Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication. J Virol (1992) 1.13
Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2. J Virol (1998) 1.11
Identification of an origin of bidirectional DNA replication in the ubiquitously expressed mammalian CAD gene. Mol Cell Biol (1995) 1.09
Stability without a centromere. Proc Natl Acad Sci U S A (1998) 1.09
Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control. Microbiol Rev (1991) 1.06
Enhancer effect of bovine papillomavirus E2 protein in replication of polyomavirus DNA. Nucleic Acids Res (1991) 1.05
The migration behaviour of DNA replicative intermediates containing an internal bubble analyzed by two-dimensional agarose gel electrophoresis. Nucleic Acids Res (1993) 0.96
Epstein-Barr virus episome-based promoter function in human myeloid cells. Nucleic Acids Res (1989) 0.94
Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene. Nucleic Acids Res (1995) 0.80
Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis. Biochemistry (1973) 43.61
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (1985) 14.39
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A (1984) 10.91
Mammalian deoxyribonucleic acid-dependent ribonucleic acid polymerases. I. Purification and properties of an -amanitin-sensitive ribonucleic acid polymerase and stimulatory factors from HeLa and KB cells. J Biol Chem (1973) 8.86
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol (1985) 7.66
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature (1989) 7.60
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol (1985) 6.44
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol (1986) 6.00
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell (1988) 5.76
Agarose slab-gel electrophoresis equipment. Anal Biochem (1975) 3.88
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene (1988) 3.42
Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol (1977) 3.11
Transcription of simian virus 40. 3. Mapping of "early" and "late" species of RNA. Proc Natl Acad Sci U S A (1973) 3.04
Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol (1995) 2.91
Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol (1979) 2.78
The structure of the termini of the DNA of Epstein-Barr virus. Cell (1979) 2.69
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol (1995) 2.45
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
Using scenarios in chronic disease management guidelines for primary care. Proc AMIA Symp (2000) 2.36
Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature (1981) 2.27
An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol (1995) 2.19
The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol (1989) 2.13
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol (2000) 2.12
Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol (1987) 1.95
The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene (1989) 1.94
Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol (1997) 1.90
DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci U S A (1991) 1.86
The PRODIGY project--the iterative development of the release one model. Proc AMIA Symp (1999) 1.82
The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol (1999) 1.80
The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J (1998) 1.73
Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro. Proc Natl Acad Sci U S A (1977) 1.68
EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol (1992) 1.66
Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J Virol (1997) 1.59
Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J Virol (1981) 1.59
Viral DNA in transformed cells. III. The amounts of different regions of the SV40 genome present in a line of transformed mouse cells. Proc Natl Acad Sci U S A (1974) 1.57
Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol (1995) 1.57
Inhibition by -amanitin of simian virus 40-specific ribonucleic acid synthesis in nuclei of infected monkey cells. J Virol (1972) 1.56
Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol (1994) 1.55
The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene (2007) 1.52
Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol (1994) 1.45
Immortalizing genes of Epstein-Barr virus. Adv Virus Res (1991) 1.45
Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol (1993) 1.44
Latency comes of age for herpesviruses. Cell (1988) 1.44
Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev Infect Dis (1983) 1.42
Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology (1974) 1.42
Multiple regions within EBNA1 can link DNAs. J Virol (1995) 1.42
Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol (1991) 1.37
Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus. J Virol (1983) 1.32
Cloning overlapping DNA fragments from the B95-8 strain of Epstein-Barr virus reveals a site of homology to the internal repetition. J Virol (1981) 1.29
Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells. J Virol (1982) 1.26
CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J (2001) 1.24
Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun (1998) 1.22
The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene (2000) 1.16
Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J Virol (1998) 1.15
The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth Differ (1991) 1.13
Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome. Virology (1982) 1.11
Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J Biol Chem (1998) 1.09
Applications of oriP plasmids and their mode of replication. Methods Enzymol (1999) 1.04
Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J Biol Chem (1997) 1.03
Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. J Virol (2000) 1.00
A chimera of EBNA1 and the estrogen receptor activates transcription but not replication. J Virol (1992) 0.98
DNA replication of herpesviruses during the lytic phase of their life-cycles. Mol Biol Med (1990) 0.94
An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained. Virology (1984) 0.93
The molecular biology of lymphotropic herpesviruses. Adv Cancer Res (1979) 0.89
The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol (2001) 0.88
An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed. Virology (1985) 0.88
Transforming functions associated with Epstein-Barr virus. J Invest Dermatol (1984) 0.84
Characterization of the BNLF-1 oncogene of Epstein-Barr virus. Curr Top Microbiol Immunol (1989) 0.83
Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation. J Virol (1993) 0.83
Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity. J Gen Virol (1999) 0.80
Epitope recognition and T cell receptors in recurrent autoimmune anterior uveitis in Lewis rats immunized with myelin basic protein. J Neuroimmunol (2000) 0.77
Importance of cryptic myelin basic protein epitopes in the pathogenicity of acute and recurrent anterior uveitis associated with EAE. J Neuroimmunol (2001) 0.76
The TextBase project--implementation of a base level message supporting electronic patient record transfer in English general practice. Proc AMIA Symp (1999) 0.75
Nitrogen turnover in man. JPEN J Parenter Enteral Nutr (1980) 0.75
Viral RNA in cells carring Epstein-Barr virus. IARC Sci Publ (1975) 0.75
Instrument shadow boards. Nurs Mirror Midwives J (1967) 0.75
Howard M. Temin: December 10, 1934-February 9, 1994. Biogr Mem Natl Acad Sci (2001) 0.75
Epstein-Barr virus. Synthesis for a complex role. Nature (1989) 0.75